PDAC
Clinical trials for PDAC explained in plain language.
Never miss a new study
Get alerted when new PDAC trials appear
Sign up with your email to follow new studies for PDAC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for pancreatic cancer: drug combo trial launches
Disease control Not yet recruitingThis study tests a new drug, telisotuzumab adizutecan, combined with standard chemotherapy (FOLFOX) in people with advanced pancreatic cancer that has spread. About 900 adults will be randomly assigned to receive either the new combination or standard treatment. The goal is to se…
Matched conditions: PDAC
Phase: PHASE2, PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated May 26, 2026 04:28 UTC
-
New drug targets Hard-to-Treat cancers with RAS mutations
Disease control Not yet recruitingThis study tests a new drug called GFH276 in people with advanced cancers that have RAS mutations, including pancreatic, lung, and colorectal cancers. The goal is to see if the drug is safe and can shrink tumors or slow disease. About 450 adults aged 18-75 will take part in two p…
Matched conditions: PDAC
Phase: PHASE1, PHASE2 • Sponsor: Genfleet Therapeutics (Shanghai) Inc. • Aim: Disease control
Last updated May 19, 2026 11:48 UTC